DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...
WALTHAM, Mass., April 27, 2011 – Alkermes, Inc. (NASDAQ: ALKS) today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in ...
Vivitrol, increasingly being tried by courts, prisons and jails across the United States to fight repeat heroin abuse, offers a long-lasting treatment option advocates say addresses the day-to-day ...
The U.S. Food & Drug Adminstration has issued a warning letter to Alkermes, Inc., the makers of Vivitrol, for failing to disclose the injectable drug's most serious risks in an advertisement. Vivitrol ...
treat alcohol dependence in people who have stopped drinking and aren’t in the hospital for treatment. prevent opioid dependence in people who have detoxed from opioids. (During opioid detox, your ...
DENVER (CBS4) - There is now a Food and Drug Administration-approved, monthly injection to treat addiction to alcohol, heroin and prescription pain pills. It's called Vivitrol. They prescribe it at ...
60.5 people in Cumberland County die from drug overdoses out of every 100,000 residents. Vivitrol was introduced in 2006. Patients only have to receive Vivitrol once a month via an injection in the ...
Vivitrol (naltrexone) is a brand-name injection that’s prescribed for alcohol or opioid dependence in adults. The cost of the drug with and without insurance can depend on several factors. Vivitrol ...
Vivitrol (naltrexone) is a brand-name injectable suspension that’s prescribed to treat alcohol or opioid dependence. Vivitrol has interactions with some other drugs. Examples include some pain ...
A print advertisement of Alkermes Plc's addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its use, the Food and Drug Administration said in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results